Endogenous plasma activated protein C levels and the effect of enoxaparin and drotrecogin alfa (activated) on markers of coagulation activation and fibrinolysis in pulmonary embolism

INTRODUCTION: There are no published data on the status of endogenous activated protein C (APC) in pulmonary embolism (PE), and no data on the effect of drotrecogin alfa (activated) (DAA) given in addition to therapeutic dose enoxaparin. METHODS: In this double-blind clinical trial, 47 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Dempfle, Carl-Erik H, Elmas, Elif, Link, Andreas, Suvajac, Nenad, Liebe, Volker, Janes, Jonathan, Borggrefe, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222057/
https://www.ncbi.nlm.nih.gov/pubmed/21241489
http://dx.doi.org/10.1186/cc9968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222057/
https://www.ncbi.nlm.nih.gov/pubmed/21241489
http://dx.doi.org/10.1186/cc9968

Ejemplares similares